P16 Expression: A marker of differentiation between childhood malignant melanomas and Spitz nevi

Journal of the American Academy of Dermatology

Volumn 65, Issue 2, 2011, Pages 357-363

  Al Dhaybi, Rola ^a   Agoumi, Mehdi ^a   Gagné, Isabelle ^a   McCuaig, Catherine ^a   Powell, Julie ^a   Kokta, Victor ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

benign melanocytic nevus; childhood; nodular melanoma; p16; Spitz nevus; Spitzoid malignant melanoma; tumor suppressor gene

Indexed keywords

KI 67 ANTIGEN; PROTEIN P16;

ARTICLE; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROL GROUP; CYTOPLASM; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JUVENILE MELANOMA; MALE; MELANOMA; MITOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD;

ADOLESCENT; BIOPSY, NEEDLE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P16; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MELANOMA; NEVUS, EPITHELIOID AND SPINDLE CELL; RISK ASSESSMENT; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79960386994     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.07.031     Document Type: Article

References (24)

1. J.L. Bader, F.P. Li, P.M. Olmstead, N.A. Strickman, and D.M. Green Childhood malignant melanoma: incidence and etiology Am J Pediatr Hematol Oncol 7 1985 341 345 (Pubitemid 16199396)
2. F. Jafarian, J. Powell, V. Kokta, M. Champagne, A. Hatami, and C. McCuaig Malignant melanoma in childhood and adolescence: a report of 13 cases J Am Acad Dermatol 53 2005 816 822 (Pubitemid 41501367)
3. S. Paradela, E. Fonseca, S. Pita, S.M. Kantrow, V.N. Goncharuk, and H. Diwan Spitzoid melanoma in children: clinicopathological study and application of immunohistochemistry as an adjunct diagnostic tool J Cutan Pathol 36 2009 740 752
4. M. Situm, Z. Bolanca, M. Buljan, D. Tomas, and M. Ivancic Nevus Spitz-everlasting diagnostic difficulties-the review Coll Antropol 32 2008 171 176
5. H. Kamino Spitzoid melanoma Clin Dermatol 27 2009 545 555
6. R. Bergman, L. Malkin, E. Sabo, and H. Kerner MIB-1 monoclonal antibody to determine proliferative activity of Ki-67 antigen as an adjunct to the histopathologic differential diagnosis of Spitz nevi J Am Acad Dermatol 44 2001 500 504 (Pubitemid 32199972)
7. P. Kapur, M.A. Selim, L. Roy, M. Yagappan, A.G. Weinberg, and M.P. Hoang Spitz nevi and atypical Spitz nevi/tumors: a histologic and immunohistochemical analysis Mod Pathol 18 2005 197 204 (Pubitemid 40188626)
8. A. Ribe, and N.S. McNutt S100A6 protein expression is different in Spitz nevi and melanomas Mod Pathol 16 2003 505 511 (Pubitemid 36618471)
9. M.S. King, S.J. Porchia, and K.M. Hiatt Differentiating Spitzoid melanomas from Spitz nevi through CD9 expression J Cutan Pathol 34 2007 576 580 (Pubitemid 46920265)
10. N.J. Hilliard, D. Krahl, and K. Sellheyer p16 Expression differentiates between desmoplastic Spitz nevus and desmoplastic melanoma J Cutan Pathol 36 2009 753 759
11. E. George, N.L. Polissar, and M. Wick Immunohistochemical evaluation of p16 INK4A, E-cadherin, and cyclin D1 expression in melanoma and Spitz tumors Am J Clin Pathol 133 2010 370 379
12. G. Massi Melanocytic nevi simulant of melanoma with medicolegal relevance Virchows Arch 451 2007 623 647 (Pubitemid 47340988)
13. + cancer stem cells in childhood malignant melanoma and its correlation with metastasis Mod Pathol 23 2010 376 380
14. J.L. Maldonado, L. Timmerman, J. Fridlyand, and B.C. Bastian Mechanisms of cell-cycle arrest in Spitz nevi with constitutive activation of the MAP-kinase pathway Am J Pathol 164 2004 1783 1787 (Pubitemid 38529780)
15. WAF1 Protein expression in melanocytic tumors by immunohistochemistry Am J Dermatopathol 20 1998 255 261 (Pubitemid 28274920)
16. S. Ohta, H. Uemura, Y. Matsui, H. Ishiguiro, K. Fujinami, and K. Kondo Alterations of p16 and p14ARF genes and their 9p21 locus in oral squamous cell carcinoma Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107 2009 81 91
17. A.D. Panani, K. Maliaga, A. Babanaraki, and I. Bellenis Numerical abnormalities of chromosome 9 and p16CDKN2A gene deletion detected by FISH in non-small cell lung cancer Anticancer Res 29 2009 4483 4487
18. S. Lakshmi, P. Rema, and T. Somanathan p16ink4a Is a surrogate marker for high-risk and malignant cervical lesions in the presence of human papillomavirus Pathobiology 76 2009 141 148
19. S. Vallian, M. Sedaghat, I. Nassiri, and A. Frazmand Methylation status of p16 INK4A tumor suppressor gene in Iranian patients with sporadic breast cancer J Cancer Res Clin Oncol 135 2009 991 996
20. R.Z. Karim, W. Li, A. Sanki, M.H. Colman, Y.H. Yang, and J.F. Thompson Reduced p16 and increased cyclin D1 and pRb expression are correlated with progression in cutaneous melanocytic tumors Int J Surg Pathol 17 2009 361 367
21. O. Straume, and L.A. Akslen Alterations and prognostic significance of p16 and p53 protein expression in subgroups of cutaneous melanoma Int J Cancer 74 1997 535 539 (Pubitemid 27486512)
22. A. Sanki, W. Li, M. Colman, R.Z. Karim, J.F. Thompson, and R.A. Scoyler Reduced expression of p16 and p27 is correlated with tumor progression in cutaneous melanoma Pathology 39 2007 551 557 (Pubitemid 350135628)
23. D. Mihic-Probst, C.D. Mnich, P.A. Oberholzer, B. Seifert, B. Sasse, and H. Moch p16 Expression in primary malignant melanoma is associated with prognosis and lymph node status Int J Cancer 118 2006 2262 2268
24. D. Bartsch, D.W. Shevlin, M.P. Callery, J.A. Northon, and P.J. Goodfellow Reduced survival in patients with ductal pancreatic adenocarcinoma associated with CDNK2 mutation J Natl Cancer Inst 88 1996 680 682 (Pubitemid 26152555)